These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17435569)

  • 1. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.
    Goforth HW; Holsinger T
    J ECT; 2007 Mar; 23(1):23-5. PubMed ID: 17435569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.
    Paul R; Schaaff N; Padberg F; Möller HJ; Frodl T
    World J Biol Psychiatry; 2009; 10(3):241-4. PubMed ID: 19224412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.
    Correll GE; Futter GE
    Pain Med; 2006; 7(1):92-5. PubMed ID: 16533209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ketamine in acute and severe major depressive disorder].
    Brittner M; Micoulaud-Franchi JA; Richieri R; Boyer L; Adida M; Lancon C; Fond G
    Presse Med; 2014 May; 43(5):492-500. PubMed ID: 24630265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder.
    Watts BV
    J ECT; 2007 Jun; 23(2):93-5. PubMed ID: 17548978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
    Campion P
    Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
    [No Abstract]   [Full Text] [Related]  

  • 9. Speed of response to electroconvulsive therapy compared with ketamine.
    Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
    Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
    [No Abstract]   [Full Text] [Related]  

  • 10. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation strategies in electroconvulsive therapy.
    Loo C; Simpson B; MacPherson R
    J ECT; 2010 Sep; 26(3):202-7. PubMed ID: 20562640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K
    Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
    Ibrahim L; Diazgranados N; Luckenbaugh DA; Machado-Vieira R; Baumann J; Mallinger AG; Zarate CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1155-9. PubMed ID: 21466832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.
    Okamoto N; Nakai T; Sakamoto K; Nagafusa Y; Higuchi T; Nishikawa T
    J ECT; 2010 Sep; 26(3):223-7. PubMed ID: 19935085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive therapy for the treatment of multiple system atrophy with major depression.
    Shioda K; Nisijima K; Kato S
    Gen Hosp Psychiatry; 2006; 28(1):81-3. PubMed ID: 16377372
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term weekly continuation electroconvulsive therapy: a case series.
    Zisselman MH; Rosenquist PB; Curlik SM
    J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
    Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.